Autolus Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Renata Kellnerova(5.5%),PPF GROUP N.V.(5.5%), etc.
Autolus Therapeutics | 10-K: Annual report
Autolus Therapeutics | 8-K: Current report
Autolus Therapeutics | 8-K/A: Current report (Amendment)
Autolus Therapeutics | 8-K: Current report
Autolus Therapeutics | D: Filing D
Autolus Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-BioNTech SE(12.5%)
Autolus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Autolus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(2.21%),Steven Boyd(2.21%)
Autolus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(6.82%),Deep Track Biotechnology Master Fund, Ltd.(6.82%), etc.
Autolus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Autolus Therapeutics | 8-K: Current report
Autolus Therapeutics | 424B5: Prospectus
Autolus Therapeutics | 8-K: Current report
Autolus Therapeutics | 8-K: Current report
Autolus Therapeutics | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Autolus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Tetragon Financial Group Limited(4.6%),Tetragon Financial Management L.P.(4.6%), etc.
Autolus Therapeutics | 8-K: Current report
Autolus Therapeutics | 8-K: Current report
Autolus Therapeutics | 8-K: Current report
No Data